GIBH-130
CAS: 1252608-59-5
Ref. 3D-CAC60859
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
GIBH-130
Description:
GIBH-130 is a potent, novel small molecule inhibitor of proinflammatory cytokines that targets the protein targets IL-1β and IL-6. In vivo efficacy has been demonstrated in murine models of CNS inflammation. GIBH-130 is a potential therapeutic for neuroinflammation and neuronal death due to its inhibition of proinflammatory cytokines. This drug also inhibits amyloid precursor protein (APP) processing and blocks the release of Aβ peptides in vitro. GIBH-130 may be an effective treatment for Alzheimer's disease as it inhibits proinflammatory cytokines, which are implicated in the etiology of this disease.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
360.41 g/mol
Formula:
C20H20N6O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
